Diagnostic performance of receptor-specific surgical specimen staining correlate with receptor expression level

Identification of tumor margins in the operating room in real time is a critical challenge for surgical procedures that serve as cancer cure. Breast conserving surgery (BCS) is particularly affected by this problem, with current reexcision rates above 25%. Due to a lack of clinically available methodologies for detection of involved or close tumor margins, much effort is focused on developing intraoperative margin assessment modalities that can aid in addressing this unmet clinical need. BCS provides a unique opportunity to design contrast-based technologies that are able to assess tumor margins independent from the patient, providing a rapid pathway from bench to bedside at a much lower cost. Since resected tissue is removed from the patient’s blood supply, non-specific contrast agent uptake becomes a challenge due to the lack of clearance. Therefore, a dual probe, ratiometric fluorescence imaging approach was taken in an effort to reduce non-specific signal, and provide a modality that could demonstrate rapid, robust margin assessment on resected patient samples. Termed, dual-stain difference specimen imaging (DDSI), DDSI includes the use of spectrally unique, and fluorescently labeled target-specific, as well as non-specific biomarkers. In the present study, we have applied epidermal growth factor receptor (EGFR) targeted DDSI to tumor xenografts with variable EGFR expression levels using a previously optimized staining protocol, allowing for a quantitative assessment of the predictive power of the technique under biologically relevant conditions. Due to the presence of necrosis in the model tumors, ring analysis was employed to characterize diagnostic accuracy as measured by receiver operator characteristic (ROC) curve analysis. Our findings demonstrate the robust nature of the DDSI technique even in the presence of variable biomarker expression and spatial patterns. These results support the continued development of this technology as a robust diagnostic tool for tumor margin assessment in resected specimens during BCS.

[1]  L. Jacobs,et al.  Annals of Surgical Oncology 15(5):1271–1272 DOI: 10.1245/s10434-007-9766-0 Positive Margins: The Challenge Continues for Breast Surgeons , 2008 .

[2]  Sheldon M. Feldman,et al.  Intra-operative Touch Preparation Cytology; Does It Have a Role in Re-excision Lumpectomy? , 2007, Annals of Surgical Oncology.

[3]  J. Cendan,et al.  Accuracy of intraoperative frozen-section analysis of breast cancer lumpectomy-bed margins. , 2005, Journal of the American College of Surgeons.

[4]  H. Feigelson,et al.  Variability in reexcision following breast conservation surgery. , 2012, JAMA.

[5]  Jonathan T. C. Liu,et al.  Surgical Guidance via Multiplexed Molecular Imaging of Fresh Tissues Labeled With SERS-Coded Nanoparticles , 2016, IEEE Journal of Selected Topics in Quantum Electronics.

[6]  Connor W. Barth,et al.  Polymeric Micelles as Carriers for Nerve-Highlighting Fluorescent Probe Delivery , 2015, Molecular pharmaceutics.

[7]  Xiaochun Xu,et al.  Microscopic investigation of" topically applied nanoparticles for molecular imaging of fresh tissue surfaces , 2018, Journal of biophotonics.

[8]  Lee G. Wilke,et al.  Intraoperative Imprint Cytology and Frozen Section Pathology for Margin Assessment in Breast Conservation Surgery: A Systematic Review , 2012, Annals of Surgical Oncology.

[9]  Brittany Lapin,et al.  Repeat surgery after breast conservation for the treatment of stage 0 to II breast carcinoma: a report from the National Cancer Data Base, 2004-2010. , 2014, JAMA surgery.

[10]  C. Cox,et al.  Surgeon Recommendations and Receipt of Mastectomy for Treatment of Breast Cancer , 2010 .

[11]  A. Saarela,et al.  Determinants of positive histologic margins and residual tumor after lumpectomy for early breast cancer: A prospective study with special reference to touch preparation cytology , 1997, Journal of surgical oncology.

[12]  A. Jemal,et al.  Cancer treatment and survivorship statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[13]  Yu Winston Wang,et al.  In vivo multiplexed molecular imaging of esophageal cancer via spectral endoscopy of topically applied SERS nanoparticles. , 2015, Biomedical optics express.

[14]  M. Nakano,et al.  Efficacy of intraoperative entire-circumferential frozen section analysis of lumpectomy margins during breast-conserving surgery for breast cancer , 2015, International Journal of Clinical Oncology.

[15]  Adam K Glaser,et al.  Raman-Encoded Molecular Imaging with Topically Applied SERS Nanoparticles for Intraoperative Guidance of Lumpectomy. , 2017, Cancer research.

[16]  Milind Rajadhyaksha,et al.  Quantitative molecular phenotyping with topically applied SERS nanoparticles for intraoperative guidance of breast cancer lumpectomy , 2016, Scientific Reports.

[17]  Stephanie Daignault,et al.  Is intraoperative frozen section analysis of reexcision specimens of value in preventing reoperation in breast-conserving therapy? , 2014, American journal of clinical pathology.

[18]  Scott C. Davis,et al.  Optimizing fresh specimen staining for rapid identification of tumor biomarkers during surgery , 2017, Theranostics.

[19]  M. Trivella,et al.  Reoperation rates after breast conserving surgery for breast cancer among women in England: retrospective study of hospital episode statistics , 2012, BMJ : British Medical Journal.

[20]  Scott C Davis,et al.  Diagnostic performance of receptor-specific surgical specimen staining correlates with receptor expression level , 2019, Journal of biomedical optics.

[21]  A. Hanlon,et al.  Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. , 1999, International journal of radiation oncology, biology, physics.

[22]  Jeffrey L Myers,et al.  Intraoperative frozen section analysis of margins in breast conserving surgery significantly decreases reoperative rates: one-year experience at an ambulatory surgical center. , 2012, American journal of clinical pathology.

[23]  M. Gnant,et al.  Intraoperative frozen section analysis for breast-conserving therapy in 1016 patients with breast cancer. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[24]  Qian Yang,et al.  High-speed Raman-encoded molecular imaging of freshly excised tissue surfaces with topically applied SERRS nanoparticles , 2018, Journal of biomedical optics.

[25]  Scott C Davis,et al.  Topical dual-stain difference imaging for rapid intra-operative tumor identification in fresh specimens. , 2013, Optics letters.

[26]  Ahmedin Jemal,et al.  Cancer treatment and survivorship statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[27]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.